Why Use Fluconazole Treatment

One of the nastiest types of infection is fungal infection.  Although they are more likely to grow on the skin, there are more serious ones though that develops in the respiratory system and infect not just the lungs, but also the blood and other parts of the body’s internal structure.  When you develop a fungal infection, it is vital that you treat the infection as soon as possible to prevent further growth, development, and spread of the infection.  Failure to do so may mean longer and costlier treatment.  Fluconazole treatment is needed for treating fungal infection.  Fluconazole treatment is an antifungal medication treatment that you take orally.

Most antifungals are applied on the skin directly to where the infection has developed.  However, if the infection has buried further or deeper in to the skin, or the infection has developed inside of the body, such topical type of antifungal will not work on such.  For cases like this, fluconazole treatment is necessary as fluconazole treatment comes in pill form which you take orally.  The treatment process in using fluconazole treatment is the purging of the infection from the inside of your body.  This effectively gets rid of the infection from your system.

For antifungal fluconazole treatment, it is necessary that you use fluconazole treatment for a course of several days.  The number of days you need to use fluconazole treatment depends on the type of infection that you have developed and the severity that it has.  Course treatment is necessary in completely getting rid of an infection from the body.  This is the very reason why doctors prescribe patients with several days of use of fluconazole treatment when they have a fungal infection.  By completing the course of fluconazole treatment, you will be able to completely purge the fungal infection out of the body. Read more…

Getting drug addiction treatment on track

Implants may trump liquid and pills

Methadone has helped countless people hooked on heroin and prescription pain relievers wean themselves off for over 40 years. A methadone alternative may soon outshine the well-known withdrawal aid in some important ways.

Buprenorphine hydrochloride, a semi-synthetic opioid compound used for pain control and detoxification, has been available in pill form for two years. But its downside includes diverting the tablets for sale on the streets and crushing and liquefying them into an injectable – and therefore more potent -- form.

A recent study published in the Journal of the American Medical Association (http://jama.ama-assn.org/cgi/content/short/304/14/1576) shows promise for a buprenorphine implant, called Probuphine by its California makers, Titan Pharmaceuticals.

One hundred and sixty-three opioid-dependent adults (18-65 years of age) received either four 3-cm long (a centimeter shy of the width of a ping-pong ball), ethylene vinyl acetate and buprenorphine implants, or 4 dummy rods for 6 months. The 108 participants with the real deal received 80 mg per implant. All the subjects were given drug counselling, and urine samples were taken to detect illicit drug use.

If anyone felt the slow-release dose from the implants did not combat their cravings sufficiently, they could request sublingual tablets. Over the first 16 weeks, about 60% of the buprenorphine group requested extra doses, while over 90% of the placebo-implanted group did. Urine samples tested negative for illicit opioids more often in the buprenorphine implant group than the placebo group (approximately 40% vs 28%) over the same timeframe. And more of the buprenorphine group opted to stay in the study for the full 24 weeks (66% vs 31%).

Cravings and other withdrawal symptoms were generally reduced in the treatment group, although there were minor adverse reactions reported, i.e. discomfort at the implant site, in both groups.

Considering that Canada ranks almost as high as Germany and the U.S. for prescription opioid use, a six-month implant may be well worth the trouble – as long as it doesn’t dissuade regular visits to the clinic for counselling.
Milena Katz